失代偿期肝硬化患者经颈静脉肝内门体分流术后腿部溃疡的愈合：可能的肝皮肤综合征病例系列
Healing of leg ulcers associated with transjugular intrahepatic portosystemic shunt in decompensated cirrhosis: case series of a possible hepatodermal syndrome.
作者信息
El Younis Cherif M, Bergasa Nora V
机构信息
Dr. El Younis serves as Chief of the Division of Gastroenterology at Brookdale University Hospital and Clinical Associate Professor of Medicine at State University of New York (SUNY) Downstate Medical Center in Brooklyn, New York. Dr. Bergasa serves as Deputy Chief of Medicine at Woodhull Medical & Mental Health Center in Brooklyn, New York, and Professor of Medicine at SUNY Downstate.
出版信息
Gastroenterol Hepatol (N Y). 2008 Mar;4(3):211-4.
Abstract
The occurrence of leg ulcers in patients with cirrhosis is not well documented in the literature. In this case series, we describe 4 patients with cirrhosis complicated by leg ulceration that failed all conventional therapy, yet healed completely following the placement of transjugular intrahepatic portosystemic shunt. The course of disease and the possibility of a hepatodermal syndrome underlying this observation are discussed.
摘要
肝硬化患者腿部溃疡的发生在文献中记载并不充分。在本病例系列中，我们描述了4例肝硬化合并腿部溃疡的患者，这些患者的溃疡在接受所有常规治疗后均未愈合，但在经颈静脉肝内门体分流术置入后完全愈合。本文讨论了疾病的进程以及这一观察结果背后存在肝皮肤综合征的可能性。
相似文献
1
2
A prospective evaluation of changes in neuropsychological and liver function tests following transjugular intrahepatic portosystemic stent-shunt.经颈静脉肝内门体分流术后神经心理学和肝功能测试变化的前瞻性评估。
J Hepatol. 1995 Dec;23(6):697-705. doi: 10.1016/0168-8278(95)80036-0.
3
Misplacement of transjugular intrahepatic portosystemic shunts: A surgical challenge for liver transplantation?经颈静脉肝内门体分流道错位：肝移植的手术挑战？
Surgery. 2021 Feb;169(2):447-454. doi: 10.1016/j.surg.2020.07.028. Epub 2020 Aug 29.
4
Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications.经颈静脉肝内门体分流术和 Alfapump®系统治疗肝硬化难治性腹水：结局和并发症。
United European Gastroenterol J. 2020 Oct;8(8):961-969. doi: 10.1177/2050640620938525. Epub 2020 Jun 26.
5
Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage.经颈静脉肝内门体分流术治疗静脉曲张出血后，对死亡率、分流失败、静脉曲张再出血和肝性脑病预测中的预后变量分析
J Hepatol. 1995 Aug;23(2):123-8. doi: 10.1016/0168-8278(95)80325-4.
6
Diastolic dysfunction on echocardiography does not predict survival after transjugular intrahepatic portosystemic stent-shunt in patients with cirrhosis.超声心动图显示舒张功能障碍不能预测肝硬化经颈静脉肝内门体分流支架植入术后患者的生存。
Aliment Pharmacol Ther. 2019 Mar;49(6):797-806. doi: 10.1111/apt.15164. Epub 2019 Feb 17.
7
Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study.经颈静脉肝内门体分流术后的门体性脑病：一项前瞻性对照研究的结果
Hepatology. 1994 Jul;20(1 Pt 1):46-55. doi: 10.1016/0270-9139(94)90133-3.
8
The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.自发性门体分流的存在会增加经颈静脉肝内门体分流术（TIPS）置入术后并发症的风险。
Diagn Interv Imaging. 2016 Jun;97(6):643-50. doi: 10.1016/j.diii.2016.02.004. Epub 2016 Mar 2.
9
Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: A systematic review and meta-analysis.经颈静脉肝内门体分流术治疗肝肾综合征：系统评价和荟萃分析。
Dig Liver Dis. 2018 Apr;50(4):323-330. doi: 10.1016/j.dld.2018.01.123. Epub 2018 Feb 17.
10
MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation.慢性肝性脑病的MRI表现取决于门体分流：一项对照前瞻性临床研究的结果
J Hepatol. 1997 Jul;27(1):121-6. doi: 10.1016/s0168-8278(97)80290-5.
本文引用的文献
1
Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascites.诱导型一氧化氮合酶活性有助于调节肝硬化腹水患者的外周血管张力。
Gut. 2006 Apr;55(4):542-6. doi: 10.1136/gut.2005.076562. Epub 2005 Nov 18.
2
Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome.肝肾综合征药物治疗的病理生理基础
Scand J Gastroenterol. 2005 May;40(5):491-500. doi: 10.1080/00365520510012064.
3
Venous ulcer: epidemiology, physiopathology, diagnosis and treatment.静脉性溃疡：流行病学、生理病理学、诊断与治疗
Int J Dermatol. 2005 Jun;44(6):449-56. doi: 10.1111/j.1365-4632.2004.02456.x.
4
Transjugular intrahepatic portosystemic shunt.经颈静脉肝内门体分流术
Dig Dis. 2005;23(1):56-64. doi: 10.1159/000084726.
5
Hepatocyte growth factor; expression, concentration and biological activity in chronic leg ulcers.肝细胞生长因子；慢性腿部溃疡中的表达、浓度及生物活性
J Dermatol Sci. 2005 Feb;37(2):75-85. doi: 10.1016/j.jdermsci.2004.11.002. Epub 2004 Dec 28.
6
Management of venous leg ulcers.下肢静脉溃疡的管理
BMJ. 2004 Jun 5;328(7452):1358-62. doi: 10.1136/bmj.328.7452.1358.
7
Management of leg ulcers.腿部溃疡的管理
Semin Cutan Med Surg. 2003 Sep;22(3):212-21. doi: 10.1016/S1085-5629(03)00043-9.
8
Inducible nitric oxide synthase expression in chronic viral hepatitis and its relation with histological severity of disease.慢性病毒性肝炎中诱导型一氧化氮合酶的表达及其与疾病组织学严重程度的关系。
J Viral Hepat. 2002 Nov;9(6):419-23. doi: 10.1046/j.1365-2893.2002.00382.x.
9
Hepatocyte growth factor may accelerate healing in chronic leg ulcers: a pilot study.肝细胞生长因子可能加速慢性腿部溃疡的愈合：一项初步研究。
J Dermatolog Treat. 2002 Jun;13(2):81-6. doi: 10.1080/095466302317584449.
10
Expression of nitric oxide synthase isoforms and arginase in normal human skin and chronic venous leg ulcers.正常人皮肤及下肢慢性静脉溃疡中一氧化氮合酶亚型和精氨酸酶的表达
J Pathol. 2000 Aug;191(4):434-42. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH654>3.0.CO;2-S.
Zotero 插件